Commission Implementing Decision (EU) 2026/68

Contents

2,898 provisions, too many to show on one page. Open a part or section to read it with its history and connections, or search inside the text.

1. THE EUROPEAN COMMISSION, Having regard to the Treaty on the Functioning of the European Union, Having regard to Regulation (EU) 2016/429 of the European Parliam
   1. (1) Infection with lumpy skin disease virus is an infectious, vector-borne disease affecting bovine animals. Its occurrence can have a severe impact on the conc
   2. (2) Commission Delegated Regulation (EU) 2020/687 supplements the rules for the control of the listed diseases referred to in Article 9(1), points (a), (b) and
   3. (3) Commission Implementing Decision (EU) 2025/1708 lays down certain emergency measures related to outbreaks of infection with lumpy skin disease virus in Fran
   4. (4) Since the last amendment of Implementing Decision (EU) 2025/1708 by Commission Implementing Decision (EU) 2025/2555, France has notified the Commission, of
   5. (5) Therefore, the areas listed as protection and surveillance zones in France, currently set out in Annex I to Implementing Decision (EU) 2025/1708, should be
   6. (6) The size of the areas indicated as protection and surveillance zones, and the duration of the measures to be applied therein, are based on the criteria laid
   7. (7) Regulation (EU) 2016/429, in particular Article 69, provides that the competent authority of a Member State may use emergency protective vaccination where n
   8. (8) In view of the spread of the disease into new areas and the consequent establishment and adjustment of the protection and surveillance zones around the outb
   9. (9) It is therefore necessary to update Annex II to Implementing Decision (EU) 2025/1708 to reflect the revised delimitation of Vaccination Zones I and II.
   10. (10) In order to ensure coordinated disease control and to safeguard trade within the Union and with third countries, the vaccination zones for infection with l
   11. (11) The type, size and duration of vaccination zones I and II set out in Parts B and A of Annex II to Implementing Decision (EU) 2025/1708 are based on the epi
   12. (12) Article 2 of Implementing Decision (EU) 2025/1708 prohibits the movements of bovine animals from the protection and surveillance zones set out in Annex I t
   13. (13) Annexes I and II to Implementing Decision (EU) 2025/1708 should, therefore, be amended accordingly.
   14. (14) In light of the current epidemiological situation in France as regards infection with lumpy skin disease virus, the amendments to be made to Annexes I and
   15. (15) The measures provided for in this Decision are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed,
2. 1
3. 2
4. I · Protection and surveillance zones established around the confirmed outbreaks
   1. Administrative area and ADIS reference number of the outbreak Areas established as protection and surveillance zones, part of the restricted zone, referred to i
5. II
   1. Part A: Vaccination zone II
   2. Part B: Vaccination zone I
6. anx_1
   1. ‘ ’